Dr. Eshan Patel, MD
Claim this profileNew York Presbyterian Brooklyn Methodist Hospital
Studies Multiple Myeloma
Studies Plasma Cell Neoplasms
1 reported clinical trial
1 drug studied
Affiliated Hospitals
More about Eshan Patel, MD
Clinical Trial Related6 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Eshan Patel, MD has experience with
- MMprofiler
Breakdown of trials Eshan Patel, MD has run
Multiple Myeloma
Plasma Cell Neoplasms
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Eshan Patel, MD specialize in?
Eshan Patel, MD focuses on Multiple Myeloma and Plasma Cell Neoplasms. In particular, much of their work with Multiple Myeloma has involved treating patients, or patients who are undergoing treatment.
Is Eshan Patel, MD currently recruiting for clinical trials?
No, Eshan Patel, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Eshan Patel, MD has studied deeply?
Yes, Eshan Patel, MD has studied treatments such as MMprofiler.
What is the best way to schedule an appointment with Eshan Patel, MD?
Apply for one of the trials that Eshan Patel, MD is conducting.
What is the office address of Eshan Patel, MD?
The office of Eshan Patel, MD is located at: New York Presbyterian Brooklyn Methodist Hospital, Brooklyn, New York 11215 United States. This is the address for their practice at the New York Presbyterian Brooklyn Methodist Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.